{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:36Z","timestamp":1791895236724,"version":"4.3.4"},"reference-count":346,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jacbts.2024.10.017","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T17:11:37Z","timestamp":1736961097000},"page":"511-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Experimental Models of Hypertrophic\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-760X","authenticated-orcid":false,"given":"Floor W.","family":"van den Dolder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafeeh","family":"Dinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.J.","family":"Warnaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofija","family":"Vu\u010dkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana S.","family":"Passadouro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhaar X.","family":"Ramsaroep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Schoonmade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Goversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2024.10.017_bib1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib2","doi-asserted-by":"crossref","first-page":"H575","DOI":"10.1152\/ajpheart.00619.2002","article-title":"Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy","volume":"284","author":"Lucas","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A\u00a0molecular basis for familial hypertrophic cardiomyopathy: a \u03b2 cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2024.10.017_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40265-022-01739-7","article-title":"Mavacamten: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jacbts.2024.10.017_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0002-9149(93)91112-U","article-title":"Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs","volume":"72","author":"Liu","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib6","first-page":"2349","article-title":"Mitochondrial DNA: hotspot for potential gene modifiers regulating hypertrophic cardiomyopathy","volume":"9","author":"Kargaran","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib7","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","article-title":"CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy","volume":"39","author":"Mosqueira","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib8","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/eurheartj\/ehw160","article-title":"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy(aEuro)","volume":"37","author":"Phelan","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/cells12020337","article-title":"Abnormal cellular phenotypes induced by three TMPO\/LAP2 variants identified in men with cardiomyopathies","volume":"12","author":"Vadrot","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jacbts.2024.10.017_bib10","article-title":"Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2","volume":"5","author":"Alvarado","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2024.10.017_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/01.RES.0000126923.46786.FD","article-title":"Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked \u03b1-tropomyosin mutations","volume":"94","author":"Coutu","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2021.04.009","article-title":"Translational investigation of electrophysiology in hypertrophic cardiomyopathy","volume":"157","author":"Flenner","year":"2021","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00395-014-0451-8","article-title":"FHL2 expression and variants in hypertrophic cardiomyopathy","volume":"109","author":"Friedrich","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcvm.2019.00170","article-title":"Differences in microRNA-29 and pro-fibrotic gene expression in mouse and human hypertrophic cardiomyopathy","volume":"6","author":"Liu","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s11248-013-9738-z","article-title":"WIF1 causes dysfunction of heart in transgenic mice","volume":"22","author":"Lu","year":"2013","journal-title":"Transgenic Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cvr\/cvx222","article-title":"Meox1 accelerates myocardial hypertrophic decompensation through Gata4","volume":"114","author":"Lu","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008639","article-title":"Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy","volume":"16","author":"Manivannan","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240129","article-title":"Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish","volume":"15","author":"Okamoto","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/dds022","article-title":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations","volume":"21","author":"Purevjav","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib21","doi-asserted-by":"crossref","first-page":"13151","DOI":"10.1111\/jcmm.15921","article-title":"ndufa7 plays a critical role in cardiac hypertrophy","volume":"24","author":"Shi","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib22","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1111\/febs.16402","article-title":"CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes","volume":"289","author":"Stathopoulou","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib23","article-title":"Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Tanaka","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s42003-022-04278-9","article-title":"A\u00a0maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology","volume":"6","author":"Viola","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/humu.23985","article-title":"Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency","volume":"41","author":"Wei","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacbts.2024.10.017_bib27","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41419-022-05403-6","article-title":"MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis","volume":"13","author":"Zou","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jacbts.2024.10.017_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003563","article-title":"Wnt signaling interactor WTIP (Wilms tumor interacting protein) underlies novel mechanism for cardiac hypertrophy","volume":"15","author":"De Jong","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4149\/gpb_2021024","article-title":"The role and the signal pathways of Yes-associated protein 2 in hypertrophic cardiomyopathy","volume":"40","author":"Song","year":"2021","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.jacbts.2024.10.017_bib30","doi-asserted-by":"crossref","first-page":"31233","DOI":"10.1074\/jbc.M301917200","article-title":"Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter","volume":"278","author":"Sucharov","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0022-2828(92)93174-I","article-title":"Myocardial contractility, lusitropy and calcium responsiveness in young (50\u00a0days) and hypertrophied (180\u00a0days) cardiomyopathic hamsters","volume":"24","author":"Antony","year":"1992","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0022-510X(93)90271-Y","article-title":"Reversal of impaired oxidative phosphorylation and calcium overloading in the in\u00a0vitro cardiac mitochondria of CHF-146 dystrophic hamsters with hereditary muscular dystrophy","volume":"120","author":"Bhattacharya","year":"1993","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02385009","article-title":"Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in Bio 14.6 cardiomyopathic hamsters at the hypertrophic stage","volume":"110","author":"Ikegaya","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0022-3565(25)22524-1","article-title":"Effect of protein kinase C on cyclic 3',5'-adenosine monophosphate- dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts","volume":"270","author":"Lee","year":"1994","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacbts.2024.10.017_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/jmcc.1994.1041","article-title":"Density of ryanodine receptors is increased in sarcoplasmic reticulum from prehypertrophic cardiomyopathic hamster heart","volume":"26","author":"Sapp","year":"1994","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0024-3205(94)00776-4","article-title":"Decreased Na,K-ATPase gene expression in cardiomyopathic hamster hearts","volume":"54","author":"Tsuruya","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1006\/jmcc.1994.1162","article-title":"Depressed responsiveness to angiotensin II in ventricular myocytes of hypertrophic cardiomyopathic syrian hamster","volume":"26","author":"Yamashita","year":"1994","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1253\/jcj.52.1156","article-title":"Spontaneously occurring hypertrophic cardiomyopathy in the rat. II. Distribution of, and correlations between, various cardiac abnormalities in the WKY\/NCrj and its related strains","volume":"52","author":"Kuribayashi","year":"1988","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/00006450-199005000-00013","article-title":"Tetralogy of Fallot, pulmonary valve stenosis, ventricular septal defect, and hypertrophic cardiomyopathy in WKY\/NCrj rats","volume":"27","author":"Kuribayashi","year":"1990","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1253\/jcj.56.441","article-title":"Echo\/Doppler diagnosis of tetralogy of Fallot, ventricular septal defect, pulmonary valve dysplasia, and hypertrophic cardiomyopathy in WKY\/NCrj rats","volume":"56","author":"Nakamura","year":"1992","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/jcj.56.376","article-title":"The beta-adrenergic receptor\/adenylate cyclase system in the cardiac ventricles of a hypertrophic cardiomyopathy rat model","volume":"56","author":"Yamamoto","year":"1992","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib42","first-page":"493","article-title":"Primary myocardial disease in the cat. A model for human cardiomyopathy","volume":"86","author":"Tilley","year":"1977","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1054-8807(94)90012-4","article-title":"Hypertrophic cardiomyopathy in pigs: quantitative pathologic features in 55 cases","volume":"3","author":"Liu","year":"1994","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1445-5994.1990.tb01294.x","article-title":"Echocardiographic and electrocardiographic study of the normal kangaroo heart","volume":"20","author":"Sugishita","year":"1990","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib45","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","article-title":"Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice","volume":"270","author":"Hunter","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib46","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI7956","article-title":"A\u00a0transgenic rabbit model for human hypertrophic cardiomyopathy","volume":"104","author":"Marian","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/hmg\/ddi002","article-title":"Expression of cardiac myosin-binding protein-C (cMyBP-C) in Drosophila as a model for the study of human cardiomyopathies","volume":"14","author":"Vu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/104063871002200320","article-title":"Sudden death associated with hypertrophic cardiomyopathy in an alpaca (Llama pacos)","volume":"22","author":"Van Alstine","year":"2010","journal-title":"J\u00a0Vet Diagn Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1242\/dmm.006148","article-title":"Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish","volume":"4","author":"Becker","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2024.10.017_bib50","first-page":"279","article-title":"Hypertrophic cardiomyopathy in owl monkeys (Aotus spp.)","volume":"63","author":"Knowlen","year":"2013","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib51","article-title":"Perturbation of the titin\/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients","volume":"12","author":"Higashikuse","year":"2019","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2024.10.017_bib52","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/hmg\/ddi146","article-title":"Fine-tuning in Ca2+ homeostasis underlies progression of cardiomyopathy in myocytes derived from genetically modified embryonic stem cells","volume":"14","author":"Grey","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jacbts.2024.10.017_bib54","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.001883","article-title":"Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity","volume":"127","author":"Liang","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.scr.2017.02.015","article-title":"Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene","volume":"20","author":"Ross","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib56","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/cvr\/cvab370","article-title":"Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart","volume":"118","author":"van der Velden","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1113\/jphysiol.2002.031922","article-title":"Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes","volume":"548","author":"Miller","year":"2003","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI12083","article-title":"Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy","volume":"107","author":"Freeman","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib59","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hc0502.103012","article-title":"Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain","volume":"105","author":"Hardt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204174119","article-title":"Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model","volume":"119","author":"Axelsson Raja","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.10.017_bib61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2014.10.069","article-title":"Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period","volume":"65","author":"Cannon","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","article-title":"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice","volume":"63","author":"Carrier","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib63","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","article-title":"Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice","volume":"90","author":"Harris","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","author":"Vignier","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI200316738","article-title":"Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy","volume":"111","author":"Song","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib66","article-title":"Replication stress response modifies sarcomeric cardiomyopathy remodeling","volume":"10","author":"Pal","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib67","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCRESAHA.118.313089","article-title":"Myofibroblast-specific TGF\u03b2 receptor II signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy","volume":"123","author":"Meng","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib68","first-page":"87","article-title":"I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model","volume":"8","author":"Friedrich","year":"2015","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib69","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ejhg.2014.211","article-title":"Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects","volume":"23","author":"Wessels","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function","volume":"117","author":"Zacchigna","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.yjmcc.2009.11.018","article-title":"Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts","volume":"48","author":"Rice","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib72","article-title":"MK2-deficient mice are bradycardic and display delayed hypertrophic remodeling in response to a chronic increase in afterload","volume":"10","author":"Ruiz","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCGENETICS.114.000957","article-title":"In\u00a0vivo analysis of troponin C knock-in (A8V) mice: evidence that TNNC1 is a hypertrophic cardiomyopathy susceptibility gene","volume":"8","author":"Martins","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.RES.0000111521.40760.18","article-title":"Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy","volume":"94","author":"Olsson","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI6067","article-title":"Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy","volume":"104","author":"Tardiff","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.yjmcc.2018.07.248","article-title":"Mutant muscle LIM protein C58G causes cardiomyopathy through protein depletion","volume":"121","author":"Ehsan","year":"2018","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib77","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yjmcc.2017.12.005","article-title":"Absence of synemin in mice causes structural and functional abnormalities in heart","volume":"114","author":"Garcia-Pelagio","year":"2018","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1603081","article-title":"Deregulated Ca(2+) cycling underlies the development of arrhythmia and heart disease due to mutant obscurin","volume":"3","author":"Hu","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacbts.2024.10.017_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114918","article-title":"MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy","volume":"9","author":"Becker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89462","article-title":"Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy","volume":"2","author":"Kimura","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2024.10.017_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003565","article-title":"Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy","volume":"10","author":"Coppini","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2024.10.017_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2013.07.011","article-title":"Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice","volume":"63","author":"St\u00f6hr","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib83","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1113\/JP273769","article-title":"Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice","volume":"595","author":"Flenner","year":"2017","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib84","article-title":"Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: a comparison of the cardiac troponin T E163R and R92Q mouse models","volume":"6","author":"Ferrantini","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib85","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.RES.88.4.383","article-title":"Comparison of two murine models of familial hypertrophic cardiomyopathy","volume":"88","author":"McConnell","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCRESAHA.115.303178","article-title":"\u03b2-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations","volume":"115","author":"Blankenburg","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib87","doi-asserted-by":"crossref","first-page":"H2148","DOI":"10.1152\/ajpheart.1999.276.6.H2148","article-title":"Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice","volume":"276","author":"Welikson","year":"1999","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib88","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/BF03401640","article-title":"Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy","volume":"2","author":"Vikstrom","year":"1996","journal-title":"Mol Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib89","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.RES.86.7.737","article-title":"Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy","volume":"86","author":"Tyska","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib90","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI11093","article-title":"An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy","volume":"106","author":"Fatkin","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI4631","article-title":"Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene","volume":"103","author":"Fatkin","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib92","doi-asserted-by":"crossref","first-page":"H807","DOI":"10.1152\/ajpheart.00913.2013","article-title":"Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy","volume":"306","author":"Barefield","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib93","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1161\/hc4701.099582","article-title":"Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant Myosin-binding protein C gene","volume":"104","author":"Berul","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/srep27714","article-title":"The embryological basis of subclinical hypertrophic cardiomyopathy","volume":"6","author":"Captur","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib95","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygeno.2007.09.005","article-title":"Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice","volume":"91","author":"Eijssen","year":"2008","journal-title":"Genomics"},{"key":"10.1016\/j.jacbts.2024.10.017_bib96","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fphys.2017.00414","article-title":"Increased postnatal cardiac hyperplasia precedes cardiomyocyte hypertrophy in a model of hypertrophic cardiomyopathy","volume":"8","author":"Farrell","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib97","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/molpharm.121.000420","article-title":"Effects of sarcomere activators and inhibitors targeting myosin cross-bridges on Ca(2+)-activation of mature and immature mouse cardiac myofilaments","volume":"101","author":"Halas","year":"2022","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2020.10.006","article-title":"Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes","volume":"150","author":"Schuldt","year":"2021","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib99","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1096\/fj.12-221994","article-title":"Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis","volume":"27","author":"Danielson","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCRESAHA.109.200964","article-title":"Truncation of titin's elastic PEVK region leads to cardiomyopathy with diastolic dysfunction","volume":"105","author":"Granzier","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib101","doi-asserted-by":"crossref","first-page":"H125","DOI":"10.1152\/ajpheart.00592.2015","article-title":"Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice","volume":"311","author":"Birch","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib102","doi-asserted-by":"crossref","first-page":"H1939","DOI":"10.1152\/ajpheart.00644.2007","article-title":"Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex","volume":"294","author":"Palmer","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib103","doi-asserted-by":"crossref","first-page":"H1136","DOI":"10.1152\/ajpheart.2001.280.3.H1136","article-title":"Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy","volume":"280","author":"Olsson","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.abb.2012.12.023","article-title":"Sexually dimorphic myofilament function and cardiac troponin i phosphospecies distribution in hypertrophic cardiomyopathy mice","volume":"535","author":"McKee","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jacbts.2024.10.017_bib105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.272.5262.731","article-title":"A\u00a0mouse model of familial hypertrophic cardiomyopathy","volume":"272","author":"Geisterfer-Lowrance","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2024.10.017_bib106","doi-asserted-by":"crossref","first-page":"H838","DOI":"10.1152\/ajpheart.00615.2006","article-title":"Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males","volume":"292","author":"Luckey","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib107","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1203\/00006450-199905010-00005","article-title":"QT dispersion in alpha-myosin heavy-chain familial hypertrophic cardiomyopathy mice","volume":"45","author":"Bevilacqua","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24676","article-title":"Soy diet worsens heart disease in mice","volume":"116","author":"Stauffer","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib109","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00424-014-1570-7","article-title":"Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice","volume":"467","author":"Najafi","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacbts.2024.10.017_bib110","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14396","article-title":"Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy","volume":"8","author":"Dieseldorff Jones","year":"2020","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cvr\/cvp016","article-title":"Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice","volume":"82","author":"Abraham","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib112","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcb.21049","article-title":"TGF\u03b2 inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway","volume":"100","author":"Rajamannan","year":"2007","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib113","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.RES.87.9.805","article-title":"Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy","volume":"87","author":"James","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib114","doi-asserted-by":"crossref","first-page":"27582","DOI":"10.1074\/jbc.M111.252320","article-title":"Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse","volume":"286","author":"Song","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphys.2013.00205","article-title":"Temporal and morphological impact of pressure overload in transgenic FHC mice","volume":"4","author":"Chen","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacbts.2015.12.001","article-title":"The role of the L-type Ca(2+) channel in altered metabolic activity in a murine model of hypertrophic cardiomyopathy","volume":"1","author":"Viola","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib117","article-title":"Micro-RNA-195 and -451 regulate the LKB1\/AMPK signaling axis by targeting MO25","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/6549","article-title":"The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation","volume":"5","author":"Georgakopoulos","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib119","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1006\/jmcc.2001.1417","article-title":"Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains","volume":"33","author":"Yang","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00395-011-0235-3","article-title":"Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy","volume":"107","author":"Schlossarek","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib121","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1038\/mtna.2013.31","article-title":"Repair of Mybpc3 mRNA by 5\u2032-trans-splicing in a mouse model of hypertrophic cardiomyopathy","volume":"2","author":"Mearini","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jacbts.2024.10.017_bib122","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/emmm.201202168","article-title":"Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice","volume":"5","author":"Gedicke-Hornung","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib123","doi-asserted-by":"crossref","first-page":"H614","DOI":"10.1152\/ajpheart.01143.2008","article-title":"Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models","volume":"297","author":"Guinto","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib124","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/CIRCULATIONAHA.118.034549","article-title":"Chronic calmodulin-kinase II activation drives disease progression in mutation-specific hypertrophic cardiomyopathy","volume":"139","author":"Lehman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib125","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1172\/JCI2389","article-title":"A\u00a0truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy","volume":"101","author":"Tardiff","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2013.02.004","article-title":"HCM-linked Delta 160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice","volume":"58","author":"Moore","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib127","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(97)83042-7","article-title":"Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6","volume":"328","author":"D'hahan","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib128","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1038\/s41598-017-08546-1","article-title":"Involvement of oxidative modification of proteins related to ATP synthesis in the left ventricles of hamsters with cardiomyopathy","volume":"7","author":"Ichihara","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0014-5793(99)01164-3","article-title":"Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by \u03b4-sarcoglycan gene transfer in\u00a0vivo","volume":"458","author":"Kawada","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jacbts.2024.10.017_bib130","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1006\/jmcc.1999.0997","article-title":"Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio 14.6 and Bio 53.58 hamsters","volume":"31","author":"Masutomo","year":"1999","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1011942824139","article-title":"Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters","volume":"224","author":"Masutomo","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0596-87","article-title":"A\u00a0genetic linkage map of the Syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping","volume":"13","author":"Okazaki","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib133","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000542-199502000-00027","article-title":"Myocardial effects of propofol in hamsters with hypertrophic cardiomyopathy","volume":"82","author":"Riou","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacbts.2024.10.017_bib134","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/bja\/77.5.653","article-title":"Myocardial effects of eltanolone in hamsters with hypertrophic cardiomyopathy","volume":"77","author":"Ruel","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacbts.2024.10.017_bib135","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1073\/pnas.94.25.13873","article-title":"Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex","volume":"94","author":"Sakamoto","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.10.017_bib136","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1536\/ihj.39.97","article-title":"Collagen synthesis by cultured cardiac fibroblasts obtained from cardiomyopathic hamsters","volume":"39","author":"Shinohara","year":"1998","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/dnares\/3.4.273","article-title":"Five candidate genes for hamster cardiomyopathy did not map to the cardiomyopathy locus by FISH analysis","volume":"3","author":"Takada","year":"1996","journal-title":"DNA Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib138","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00000542-199712000-00020","article-title":"Myocardial effects of halothane and isoflurane in hamsters with hypertrophic cardiomyopathy","volume":"87","author":"Vivien","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacbts.2024.10.017_bib139","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00000542-199811000-00020","article-title":"Myocardial effects of desflurane in hamsters with hypertrophic cardiomyopathy","volume":"89","author":"Vivien","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacbts.2024.10.017_bib140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000539-200207000-00005","article-title":"The paradoxical positive inotropic effect of sevoflurane in healthy and cardiomyopathic hamsters","volume":"95","author":"Vivien","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacbts.2024.10.017_bib141","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3390\/nu14163287","article-title":"Short-communication: short-term treatment with taurine prevents the development of cardiac hypertrophy and early death in hereditary cardiomyopathy of the hamster and is sex-dependent","volume":"14","author":"Bkaily","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jacbts.2024.10.017_bib142","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.yjmcc.2005.01.003","article-title":"NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy: Prevention by NHE-1 inhibitor","volume":"38","author":"Chahine","year":"2005","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib143","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.1717","article-title":"Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy","volume":"205","author":"Fiaccavento","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib144","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cardiores.2003.08.005","article-title":"Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts","volume":"60","author":"Masuelli","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1025542731335","article-title":"Identification of a new missense mutation in the mtDNA of hereditary hypertrophic, but not dilated cardiomyopathic hamsters","volume":"252","author":"Minieri","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib146","first-page":"H999","article-title":"Calcium currents in ventricular myocytes of prehypertrophic cardiomyopathic hamsters","volume":"268","author":"Li","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib147","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0940-2993(98)80092-4","article-title":"Morphological investigations of the myocardium of cardiomyopathic hamsters during the postnatal development and experimental hypoxia. A quantitative ultrastructural study","volume":"50","author":"Fitzl","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib148","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02985000","article-title":"Abnormal retention of 99mTc-TF in a hamster model of cardiomyopathy analyzed by 99mTc-TF and 125I-BMIPP autoradiography","volume":"18","author":"Lwin","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib149","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s11427-019-1627-y","article-title":"MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway","volume":"63","author":"Chen","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41434-023-00384-3","article-title":"Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy","volume":"30","author":"Nie","year":"2023","journal-title":"Gene Ther"},{"key":"10.1016\/j.jacbts.2024.10.017_bib151","doi-asserted-by":"crossref","first-page":"H1260","DOI":"10.1152\/ajpheart.00519.2015","article-title":"Rat cardiac troponin T mutation (F72l)-mediated impact on thin filament cooperativity is divergently modulated by \u03b1- and \u03b2-myosin heavy chain isoforms","volume":"309","author":"Chandra","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib152","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0008-6363(00)00114-0","article-title":"Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias","volume":"47","author":"Frey","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib153","doi-asserted-by":"crossref","first-page":"29575","DOI":"10.1074\/jbc.M507740200","article-title":"Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy","volume":"281","author":"Frey","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib154","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-008-0436-x","article-title":"Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy","volume":"87","author":"Luedde","year":"2009","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jacbts.2024.10.017_bib155","doi-asserted-by":"crossref","first-page":"R685","DOI":"10.1152\/ajpregu.00620.2003","article-title":"alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways","volume":"287","author":"Wernicke","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib156","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1515\/BMT.2007.010","article-title":"Autonomic cardiac control in animal models of cardiovascular diseases II. Variability analysis in transgenic rats with alpha-tropomyosin mutations Asp175Asn and Glu180Gly","volume":"52","author":"Wernicke","year":"2007","journal-title":"Biomed Tech (Berl)"},{"key":"10.1016\/j.jacbts.2024.10.017_bib157","doi-asserted-by":"crossref","first-page":"H1514","DOI":"10.1152\/ajpheart.01283.2007","article-title":"The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy","volume":"294","author":"Bell","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib158","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1152\/physiolgenomics.00143.2017","article-title":"Involvement of human monogenic cardiomyopathy genes in experimental polygenic cardiac hypertrophy","volume":"50","author":"Prestes","year":"2018","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jacbts.2024.10.017_bib159","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.fjc.0000248236.43760.86","article-title":"Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy","volume":"48","author":"de Resende","year":"2006","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib160","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib161","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.CIR.102.12.1346","article-title":"Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"102","author":"Nagueh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib162","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.yjmcc.2004.02.010","article-title":"Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"36","author":"Nagueh","year":"2004","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib163","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.CIR.104.3.317","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib164","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCRESAHA.107.161240","article-title":"Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"101","author":"Ripplinger","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","article-title":"Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"97","author":"Senthil","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib166","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1073\/pnas.1802967115","article-title":"Hypertrophic cardiomyopathy R403Q mutation in rabbit \u03b2-myosin reduces contractile function at the molecular and myofibrillar levels","volume":"115","author":"Lowey","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.10.017_bib167","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.RES.77.1.98","article-title":"Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes","volume":"77","author":"Marian","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib168","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/01.CIR.0000164234.24957.75","article-title":"Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy","volume":"111","author":"Sanbe","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib169","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2460\/javma.259.7.764","article-title":"Clinical and pathological findings in rabbits with cardiovascular disease: 59 cases (2001-2018)","volume":"259","author":"Ozawa","year":"2021","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib170","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/1098612X211021819","article-title":"The feline cardiomyopathies: 1. General concepts","volume":"23","author":"Kittleson","year":"2021","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.jacbts.2024.10.017_bib171","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats","volume":"34","author":"Luis Fuentes","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib172","first-page":"155","article-title":"Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed","volume":"12","author":"Mary","year":"2010","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib173","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1939-1676.2008.0113.x","article-title":"Prevalence of the myosin-binding protein C mutation in Maine Coon cats","volume":"22","author":"Fries","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib174","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1939-1676.2008.0218.x","article-title":"Prospective echocardiographic and tissue doppler imaging screening of a population of Maine Coon Cats tested for the A31P mutation in the myosin-binding protein C gene: a specific analysis of the heterozygous status","volume":"23","author":"Sampedrano","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1751-0147-53-7","article-title":"Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation - the clinical significance of having the mutation","volume":"53","author":"Godiksen","year":"2011","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.jacbts.2024.10.017_bib176","first-page":"S268","article-title":"Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study","volume":"17","author":"Granstrom","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib177","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","article-title":"A\u00a0substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy","volume":"90","author":"Meurs","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.jacbts.2024.10.017_bib178","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fphys.2017.00348","article-title":"Investigations into the sarcomeric protein and Ca(2+)-regulation abnormalities underlying hypertrophic cardiomyopathy in cats (Felix catus)","volume":"8","author":"Messer","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib179","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijcard.2010.04.032","article-title":"The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans","volume":"145","author":"Vera","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib180","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/s41431-019-0431-4","article-title":"A\u00a0feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat","volume":"27","author":"Schipper","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib181","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1212\/01.wnl.0000257131.13438.2c","article-title":"Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy","volume":"68","author":"Tajsharghi","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2024.10.017_bib182","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.608473","article-title":"A\u00a0novel homozygous intronic variant in TNNT2 associates with feline cardiomyopathy","volume":"11","author":"McNamara","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib183","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-021-01740-5","article-title":"A\u00a0deleterious mutation in the ALMS1 gene in a naturally occurring model of hypertrophic cardiomyopathy in the Sphynx cat","volume":"16","author":"Meurs","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacbts.2024.10.017_bib184","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2017.05.017","article-title":"Characteristics of cardiomyopathy in Alstrom syndrome: Prospective single-center data on 38 patients","volume":"121","author":"Brofferio","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacbts.2024.10.017_bib185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcpa.2011.11.196","article-title":"Diagnostic value of morphometry in feline hypertrophic cardiomyopathy","volume":"147","author":"Kershaw","year":"2012","journal-title":"J\u00a0Comp Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib186","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0300985819837717","article-title":"Feline hypertrophic cardiomyopathy: the consequence of cardiomyocyte-initiated and macrophage-driven remodeling processes?","volume":"56","author":"Kitz","year":"2019","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib187","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1939-1676.2012.00906.x","article-title":"Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: a retrospective analysis of 344 cases (2001-2011)","volume":"26","author":"Trehiou-Sechi","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib188","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1054-8807(98)00031-3","article-title":"Characterization and quantitation of extracellular collagen matrix in myocardium of pigs with spontaneously occurring hypertrophic cardiomyopathy","volume":"8","author":"Chiu","year":"1999","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib189","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1096\/fasebj.10.10.8751722","article-title":"Substantial decrease of heat shock protein 90 in ventricular tissues of two sudden-death pigs with hypertrophic cardiomyopathy","volume":"10","author":"Lee","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib190","first-page":"1253","article-title":"Alteration of endogenous antioxidant enzymes in naturally occurring hypertrophic cardiomyopathy","volume":"43","author":"Lin","year":"1997","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.jacbts.2024.10.017_bib191","first-page":"238","article-title":"Echocardiographic features of pigs with spontaneous hypertrophic cardiomyopathy","volume":"52","author":"Lin","year":"2002","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib192","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0034-5288(02)00189-3","article-title":"Structural and biochemical evidence of mitochondrial depletion in pigs with hypertrophic cardiomyopathy","volume":"74","author":"Lin","year":"2003","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib193","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1054-8807(01)00101-6","article-title":"Ultrastructure of intramural coronary arteries in pigs with hypertrophic cardiomyopathy","volume":"11","author":"Shyu","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib194","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41598-018-22936-z","article-title":"Successful knock-in of hypertrophic cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs","volume":"8","author":"Montag","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacbts.2019.03.004","article-title":"Extracellular matrix from hypertrophic myocardium provokes impaired twitch dynamics in healthy cardiomyocytes","volume":"4","author":"Sewanan","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib196","first-page":"333","article-title":"Antemortem screening for left ventricular hypertrophy in rhesus macaques (Macaca mulatta)","volume":"66","author":"Haertel","year":"2016","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib197","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jmp.12127","article-title":"Large-scale pedigree analysis leads to evidence for founder effects of hypertrophic cardiomyopathy in rhesus macaques (Macaca mulatta)","volume":"43","author":"Kanthaswamy","year":"2014","journal-title":"J\u00a0Med Primatol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib198","doi-asserted-by":"crossref","first-page":"358","DOI":"10.30802\/AALAS-CM-19-000108","article-title":"MYBPC3 haplotype linked to hypertrophic cardiomyopathy in rhesus macaques (Macaca mulatta)","volume":"70","author":"Oldt","year":"2020","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib199","first-page":"162","article-title":"Left ventricular hypertrophy in rhesus macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014)","volume":"66","author":"Reader","year":"2016","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2019.00001","article-title":"Heart rate and heart rate variability of rhesus macaques (Macaca mulatta) affected by left ventricular hypertrophy","volume":"6","author":"Ueda","year":"2019","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib201","doi-asserted-by":"crossref","first-page":"348","DOI":"10.30802\/AALAS-CM-19-000117","article-title":"Identifying cardiac diseases using cardiac biomarkers in rhesus macaques (Macaca mulatta)","volume":"70","author":"Ueda","year":"2020","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib202","first-page":"347","article-title":"Vertebral heart score in rhesus macaques (Macaca mulatta): generating normal reference intervals and assessing its validity for identifying cardiac disease","volume":"59","author":"Williams","year":"2020","journal-title":"J\u00a0Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib203","first-page":"964","article-title":"Raf-mediated cardiac hypertrophy in adult Drosophila","volume":"6","author":"Yu","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2024.10.017_bib204","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045377","article-title":"Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and tetralogy of fallot and its functional evaluation in the Drosophila heart","volume":"13","author":"Auxerre-Planti\u00e9","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2024.10.017_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192416554","article-title":"Regular exercise rescues heart function defects and shortens the lifespan of Drosophila caused by dMnM downregulation","volume":"19","author":"Gu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacbts.2024.10.017_bib206","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1113\/JP277333","article-title":"The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production","volume":"597","author":"Bell","year":"2019","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib207","doi-asserted-by":"crossref","first-page":"29270","DOI":"10.1074\/jbc.M115.681874","article-title":"A\u00a0failure to communicate: myosin residues involved in hypertrophic cardiomyopathy affect inter-domain interaction","volume":"290","author":"Kronert","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib208","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38064","article-title":"Prolonged cross-bridge binding triggers muscle dysfunction in a Drosophila model of myosin-based hypertrophic cardiomyopathy","volume":"7","author":"Kronert","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jacbts.2024.10.017_bib209","first-page":"1137","article-title":"Myosin transducer inter-strand communication is critical for normal ATPase activity and myofibril structure","volume":"11","author":"Kronert","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jacbts.2024.10.017_bib210","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkaa014","article-title":"Heat shock proteins and small nucleolar RNAs are dysregulated in a Drosophila model for feline hypertrophic cardiomyopathy","volume":"11","author":"Tallo","year":"2021","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.jacbts.2024.10.017_bib211","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1038\/s41467-020-15922-5","article-title":"A\u00a0role for actin flexibility in thin filament-mediated contractile regulation and myopathy","volume":"11","author":"Viswanathan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2024.10.017_bib212","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.celrep.2017.08.070","article-title":"Distortion of the actin A-triad results in contractile disinhibition and cardiomyopathy","volume":"20","author":"Viswanathan","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib213","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2024.10.017_bib214","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1002\/jcp.29441","article-title":"Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model","volume":"235","author":"Da'as","year":"2020","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib215","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.3390\/ijms23168840","article-title":"Transcriptome profile identifies actin as an essential regulator of cardiac myosin binding protein C3 hypertrophic cardiomyopathy in a zebrafish model","volume":"23","author":"Da'as","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.839862","article-title":"A\u00a0novel missense variant in actin binding Domain of MYH7 is associated with left ventricular noncompaction","volume":"9","author":"Hesaraki","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib217","doi-asserted-by":"crossref","first-page":"H1594","DOI":"10.1152\/ajpheart.00637.2013","article-title":"Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models","volume":"307","author":"Hodatsu","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib218","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41436-020-01028-2","article-title":"Autosomal recessive cardiomyopathy and sudden cardiac death associated with variants in MYL3","volume":"23","author":"Osborn","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib219","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41467-018-07054-8","article-title":"Loss of embryonic neural crest derived cardiomyocytes causes adult onset hypertrophic cardiomyopathy in zebrafish","volume":"9","author":"Abdul-Wajid","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2024.10.017_bib220","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1093\/nar\/gkz218","article-title":"Deletion of Gtpbp3 in zebrafish revealed the hypertrophic cardiomyopathy manifested by aberrant mitochondrial tRNA metabolism","volume":"47","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib221","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1093\/nar\/gkab228","article-title":"Ablation of Mto1 in zebrafish exhibited hypertrophic cardiomyopathy manifested by mitochondrion RNA maturation deficiency","volume":"49","author":"Zhang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib222","first-page":"19","article-title":"Study on electrocardiographic, echocardiographic and biochemical blood parameters in hypertrophic cardiomyopathy in dogs","volume":"28","author":"Simiz","year":"2018","journal-title":"Rev Romana Med Veter"},{"key":"10.1016\/j.jacbts.2024.10.017_bib223","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jvim.16402","article-title":"Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs","volume":"36","author":"Schober","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib224","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.rvsc.2015.08.004","article-title":"Anatomopathological staging of feline hypertrophic cardiomyopathy through quantitative evaluation based on morphometric and histopathological data","volume":"102","author":"Biasato","year":"2015","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00395-013-0349-x","article-title":"Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue","volume":"108","author":"Crocini","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib226","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009140","article-title":"Combinatorial effects of double cardiomyopathy mutant alleles in rodent myocytes: a predictive cellular model of myofilament dysregulation in disease","volume":"5","author":"Davis","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2020.08.101","article-title":"The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes","volume":"323","author":"Dorsch","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib228","first-page":"195","article-title":"COOH-terminal truncated cardiac myosin binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered incorporation into fetal rat cardiomyocytes","volume":"100","author":"Flavigny","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib229","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physiolgenomics.00099.2001","article-title":"Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins","volume":"9","author":"Michele","year":"2002","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jacbts.2024.10.017_bib230","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/15353702211072453","article-title":"Allele-specific silencing by RNAi of R92Q and R173W mutations in cardiac troponin T","volume":"247","author":"Migliore","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jacbts.2024.10.017_bib231","doi-asserted-by":"crossref","first-page":"H715","DOI":"10.1152\/ajpheart.00023.2020","article-title":"Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca(2+) flux caused by thin filament hypertrophic cardiomyopathy mutations","volume":"318","author":"Sparrow","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib232","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2015.08.020","article-title":"The E3 ubiquitin ligase Asb2\u03b2 is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation","volume":"87","author":"Thottakara","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib233","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1242\/jcs.00709","article-title":"Mutations in the motor domain modulate myosin activity and myofibril organization","volume":"116","author":"Wang","year":"2003","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib234","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.0000034710.46739.C0","article-title":"Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants","volume":"91","author":"Westfall","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1536\/ihj.20-351","article-title":"FLNC and MYLK2 gene mutations in a Chinese family with different phenotypes of cardiomyopathy","volume":"62","author":"Qin","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111736","article-title":"Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells","volume":"387","author":"Cai","year":"2020","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102566","article-title":"Generation of a homozygous MYH7 gene knockout human embryonic stem cell line (WAe009-A-69) using an episomal vector-based CRISPR\/Cas9 system","volume":"57","author":"Guo","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101930","article-title":"Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR\/Cas9 system","volume":"48","author":"Wu","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib239","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yjmcc.2016.09.004","article-title":"Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes","volume":"99","author":"Monteiro da Rocha","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41419-019-1826-4","article-title":"MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jacbts.2024.10.017_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.585879","article-title":"RAD-deficient human cardiomyocytes develop hypertrophic cardiomyopathy phenotypes due to calcium dysregulation","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib242","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacbts.2024.10.017_bib243","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib244","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib245","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib246","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib247","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib248","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A\u00a0premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay","volume":"139","author":"Seeger","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib249","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.120.047999","article-title":"Development of a cardiac sarcomere functional genomics platform to enable scalable interrogation of human TNNT2 variants","volume":"142","author":"Pettinato","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities","volume":"15","author":"Ben Jehuda","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacbts.2024.10.017_bib251","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1684792","article-title":"Mutation-specific phenotypes in hiPSC-derived cardiomyocytes carrying either myosin-binding protein C Or \u03b1-tropomyosin mutation for hypertrophic cardiomyopathy","volume":"2016","author":"Ojala","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jacbts.2024.10.017_bib252","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCGEN.119.002823","article-title":"Genetic studies of hypertrophic cardiomyopathy in Singaporeans identify variants in TNNI3 and TNNT2 that are common in Chinese patients","volume":"13","author":"Pua","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib253","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.121.056265","article-title":"Muscle LIM protein force-sensing mediates sarcomeric biomechanical signaling in human familial hypertrophic cardiomyopathy","volume":"145","author":"Riaz","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib254","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","article-title":"Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients","volume":"40","author":"Wu","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib255","doi-asserted-by":"crossref","first-page":"35376","DOI":"10.1021\/acsami.2c07326","article-title":"Contractility and calcium transient maturation in the human iPSC-derived cardiac microfibers","volume":"14","author":"Strimaityte","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jacbts.2024.10.017_bib256","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12195-021-00684-x","article-title":"Interplay of genotype and substrate stiffness in driving the hypertrophic cardiomyopathy phenotype in iPSC-micro-heart muscle arrays","volume":"14","author":"Guo","year":"2021","journal-title":"Cell Mol Bioeng"},{"key":"10.1016\/j.jacbts.2024.10.017_bib257","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.122.321956","article-title":"Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM","volume":"132","author":"Pioner","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.894635","article-title":"Myosin heavy chain converter domain mutations drive early-stage changes in extracellular matrix dynamics in hypertrophic cardiomyopathy","volume":"10","author":"Hsieh","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib259","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib260","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"Macleod","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jacbts.2024.10.017_bib261","article-title":"Reporting In\u00a0vitro Experiments Responsibly - the RIVER Recommendations","year":"2023","journal-title":"MetaArXiv"},{"key":"10.1016\/j.jacbts.2024.10.017_bib262","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-018-2214-0","article-title":"Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review","volume":"471","author":"Eschenhagen","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacbts.2024.10.017_bib263","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib264","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/HYPERTENSIONAHA.113.02526","article-title":"Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2024.10.017_bib265","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in\u00a0vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib266","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cvr\/cvz218","article-title":"Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy","volume":"116","author":"Huang","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib267","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s44161-024-00505-0","article-title":"Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy","volume":"3","author":"Hartman","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib268","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/fcp.12031","article-title":"AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1","volume":"28","author":"Vignier","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib269","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fphys.2014.00484","article-title":"Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy","volume":"5","author":"Schlossarek","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib270","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fphys.2017.00558","article-title":"Nebivolol desensitizes myofilaments of a hypertrophic cardiomyopathy mouse model","volume":"8","author":"St\u00fccker","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib271","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/jvim.14568","article-title":"Platelet activation and clopidogrel effects on ADP-induced platelet activation in cats with or without the A31P mutation in MYBPC3","volume":"30","author":"Li","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib272","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1371781","article-title":"Evaluation of clopidogrel response in healthy cats using a novel viscoelastic test and thromboelastography","volume":"11","author":"Rosati","year":"2024","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib273","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62840-3","article-title":"Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy","volume":"14","author":"Rivas","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2024.10.017_bib274","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168407","article-title":"A\u00a0small molecule inhibitor of sarcomere contractility acutely relieves left ventricular outflow tract obstruction in feline hypertrophic cardiomyopathy","volume":"11","author":"Stern","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib275","doi-asserted-by":"crossref","first-page":"796","DOI":"10.14202\/vetworld.2024.796-803","article-title":"Rivaroxaban versus enoxaparin plus clopidogrel therapy for hypertrophic cardiomyopathy-associated thromboembolism in cats","volume":"17","author":"Jaturanratsamee","year":"2024","journal-title":"Vet World"},{"key":"10.1016\/j.jacbts.2024.10.017_bib276","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007022","article-title":"Proteomic and functional studies reveal detyrosinated tubulin as treatment target in sarcomere mutation-induced hypertrophic cardiomyopathy","volume":"14","author":"Schuldt","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2024.10.017_bib277","article-title":"Unraveling the genotype-phenotype relationship in hypertrophic cardiomyopathy: obesity-related cardiac defects as a major disease modifier","volume":"9","author":"Nollet","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib278","article-title":"Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: a two-hit model of hypertrophic cardiomyopathy","volume":"6","author":"Nollet","year":"2023","journal-title":"J\u00a0Mol Cell Cardiol Plus"},{"key":"10.1016\/j.jacbts.2024.10.017_bib279","article-title":"Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart function","author":"Pietsch","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jacbts.2024.10.017_bib280","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/cvr\/cvy147","article-title":"Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"van der Velden","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib281","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004369","article-title":"Integrating clinical phenotype with multiomics analyses of human cardiac tissue unveils divergent metabolic remodeling in genotype-positive and genotype-negative patients with hypertrophic cardiomyopathy","volume":"17","author":"Nollet","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib282","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13287-022-03021-9","article-title":"Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling","volume":"13","author":"Vuckovic","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jacbts.2024.10.017_bib283","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004133","article-title":"Sex differences at the time of myectomy in hypertrophic cardiomyopathy","volume":"11","author":"Nijenkamp","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2024.10.017_bib284","article-title":"Sex-related differences in genetic cardiomyopathies","volume":"11","author":"Argiro","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib285","article-title":"Clinical outcomes in patients with nonobstructive, labile, and obstructive hypertrophic cardiomyopathy","volume":"7","author":"Lu","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2024.10.017_bib286","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2004.12.067","article-title":"The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms","volume":"45","author":"Autore","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib287","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","article-title":"Hypertrophic cardiomyopathy","volume":"363","author":"Elliott","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib288","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2024.10.017_bib289","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221136074","article-title":"Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten","volume":"13","author":"Mathai","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jacbts.2024.10.017_bib290","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/1098612X211020162","article-title":"The feline cardiomyopathies:. 2. Hypertrophic cardiomyopathy","volume":"23","author":"Kittleson","year":"2021","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.jacbts.2024.10.017_bib291","first-page":"268","article-title":"Echocardiographic characterization of a murine model of hypertrophic obstructive cardiomyopathy induced by cardiac-specific overexpression of epidermal growth factor receptor 2","volume":"66","author":"S\u00f8rensen","year":"2016","journal-title":"Comp Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib292","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.jacbts.2024.10.017_bib293","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232427","article-title":"Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy","volume":"15","author":"Nijenkamp","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib294","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/eci.12544","article-title":"Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype","volume":"45","author":"Guclu","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacbts.2024.10.017_bib295","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\"small vessel\") coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib296","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","article-title":"Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy","volume":"75","author":"Tanaka","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib297","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.97.3.230","article-title":"Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation","volume":"97","author":"Krams","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib298","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12265-009-9142-5","article-title":"Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy","volume":"2","author":"Cecchi","year":"2009","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib299","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib300","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.76.6.1214","article-title":"Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography","volume":"76","author":"O'Gara","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib301","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib302","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/hrt.77.6.558","article-title":"Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy","volume":"77","author":"Crowley","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2024.10.017_bib303","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.71.2.234","article-title":"Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures","volume":"71","author":"Cannon","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib304","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0002-9149(77)90151-5","article-title":"Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis","volume":"40","author":"Pichard","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib305","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","article-title":"Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy","volume":"49","author":"Sotgia","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib306","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5455\/OVJ.2021.v11.i3.20","article-title":"Findings suggestive of coronary microvascular dysfunction in cats with myocardial ischemia","volume":"11","author":"Belerenian","year":"2021","journal-title":"Open Vet J"},{"key":"10.1016\/j.jacbts.2024.10.017_bib307","first-page":"S329","article-title":"Cardiac pathology findings in. 252 cats presented for necropsy; a comparison of cats with unexpected death versus other deaths","volume":"17","author":"Wilkie","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib308","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.99.24.3172","article-title":"Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease","volume":"99","author":"Kittleson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib309","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1354\/vp.42-4-458","article-title":"Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy","volume":"42","author":"Cesta","year":"2005","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib310","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1292\/jvms.63.583","article-title":"Hypertrophic cardiomyopathy in two kittens","volume":"63","author":"Fujii","year":"2001","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.jacbts.2024.10.017_bib311","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/03009858211062631","article-title":"Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells","volume":"59","author":"Rodriguez","year":"2022","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib312","doi-asserted-by":"crossref","first-page":"H881","DOI":"10.1152\/ajpheart.00345.2020","article-title":"Mavacamten decreases maximal force and Ca(2+) sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy","volume":"320","author":"Awinda","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib313","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12968-021-00754-z","article-title":"Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy","volume":"23","author":"Ku","year":"2021","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacbts.2024.10.017_bib314","article-title":"A\u00a0murine hypertrophic cardiomyopathy model: the DBA\/2J strain","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib315","doi-asserted-by":"crossref","first-page":"H2244","DOI":"10.1152\/ajpheart.00606.2002","article-title":"Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy","volume":"283","author":"Petersen","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib316","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1006\/jmcc.2001.1466","article-title":"A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy","volume":"33","author":"Semsarian","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib317","doi-asserted-by":"crossref","first-page":"18123","DOI":"10.1073\/pnas.0509145102","article-title":"Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.10.017_bib318","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/CIRCRESAHA.120.318674","article-title":"Efficient correction of a hypertrophic cardiomyopathy mutation by ABEmax-NG","volume":"129","author":"Ma","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib319","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI118992","article-title":"Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart","volume":"98","author":"Jones","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jacbts.2024.10.017_bib320","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","article-title":"Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice","volume":"90","author":"Harris","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib321","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","article-title":"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice","volume":"63","author":"Carrier","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib322","doi-asserted-by":"crossref","first-page":"H620","DOI":"10.1152\/ajpheart.00167.2017","article-title":"Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model","volume":"313","author":"Toib","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib323","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003565","article-title":"Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy","volume":"10","author":"Coppini","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2024.10.017_bib324","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.yjmcc.2006.07.016","article-title":"Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy","volume":"41","author":"Tsoutsman","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib325","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCULATIONAHA.107.755777","article-title":"Severe heart failure and early mortality in a double mutation mouse model of familial hypertrophic cadiomyopathy","volume":"117","author":"Tsoutsman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2024.10.017_bib326","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.RES.85.1.47","article-title":"Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction","volume":"85","author":"Muthuchamy","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib327","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1006\/jmcc.2001.1445","article-title":"A familial hypertrophic cardiomyopathy \u03b1 tropomyosin mutation causes severe cardiac hypertrophy and death in mice","volume":"33","author":"Prabhakar","year":"2001","journal-title":"J Mol Cellular Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib328","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1025409227350","article-title":"A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation","volume":"251","author":"Prabhakar","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib329","doi-asserted-by":"crossref","first-page":"28925","DOI":"10.1074\/jbc.M113.466466","article-title":"Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy","volume":"288","author":"Schulz","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacbts.2024.10.017_bib330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCGENETICS.113.000324","article-title":"Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins","volume":"7","author":"Alves","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacbts.2024.10.017_bib331","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007172","article-title":"Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib332","doi-asserted-by":"crossref","first-page":"E4138","DOI":"10.1073\/pnas.1505819112","article-title":"Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice","volume":"112","author":"Yuan","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.10.017_bib333","doi-asserted-by":"crossref","first-page":"H575","DOI":"10.1152\/ajpheart.00107.2013","article-title":"Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy","volume":"305","author":"Kazmierczak","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib334","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042805","article-title":"Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice","volume":"7","author":"Sysa-Shah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2024.10.017_bib335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvu214","article-title":"Development of hypertrophic cardiomyopathy in perilipin1 null mice with adipose tissue dysfunction","volume":"105","author":"Liu","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib336","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00110.2003","article-title":"Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart","volume":"286","author":"Zheng","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib337","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/cvr\/cvab077","article-title":"Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes","volume":"118","author":"Ramachandra","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib338","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stemcr.2018.11.015","article-title":"A contraction stress model of hypertrophic cardiomyopathy due to sarcomere Mutations","volume":"12","author":"Cohn","year":"2019","journal-title":"Stem Cell Report"},{"key":"10.1016\/j.jacbts.2024.10.017_bib339","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patientspecific induced pluripotent stem cells","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2020.06.003","article-title":"Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics","volume":"145","author":"Bhagwan","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib341","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.stemcr.2016.04.006","article-title":"Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"6","author":"Pioner","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jacbts.2024.10.017_bib342","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003522","article-title":"Human-induced pluripotent stem cell-derived cardiomyocyte model for TNNT2 Delta160E-induced cardiomyopathy","volume":"15","author":"Kondo","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib343","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yjmcc.2017.12.002","article-title":"Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes","volume":"114","author":"Wang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.10.017_bib344","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911115","article-title":"Disease modeling of a mutation in \u03b1actinin 2 guides clinical therapy in hypertrophic cardiomyopathy","volume":"11","author":"Prondzynski","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jacbts.2024.10.017_bib345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12265-019-09873-6","article-title":"Induced pluripotent stem cell-derived cardiomyocytes from a patient with MYL2-R58Q-mediated apical hypertrophic cardiomyopathy show hypertrophy, myofibrillar disarray, and calcium perturbations","volume":"12","author":"Zhou","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jacbts.2024.10.017_bib346","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.stemcr.2018.01.013","article-title":"Mitochondrial dysfunctions contribute to hypertrophic cardiomyopathy in Patient iPSC-derived cardiomyocytes with MT-RNR2 Mutation","volume":"10","author":"Li","year":"2018","journal-title":"Stem Cell Rep"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X24003966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X24003966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T14:31:07Z","timestamp":1745850667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X24003966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":346,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2452302X24003966"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.10.017","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental Models of Hypertrophic\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}